You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 57 No. 4, April 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (124)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neurology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Subthalamic Stimulation in Parkinson Disease

A Multidisciplinary Approach

J. L. Houeto, MD; P. Damier, MD, PhD; P. B. Bejjani, MD; C. Staedler, MD; A. M. Bonnet, MD; I. Arnulf, MD; B. Pidoux, MD, PhD; D. Dormont, MD; P. Cornu, MD; Y. Agid, MD, PhD

Arch Neurol. 2000;57:461-465.

Background  High-frequency stimulation of the subthalamic nucleus constitutes a therapeutic advance for severely disabled patients with Parkinson disease.

Objective  To evaluate the efficacy and safety of continuous bilateral high-frequency stimulation of the subthalamic nucleus in patients with Parkinson disease.

Design  A prospective study of patients with Parkinson disease treated at a university hospital.

Patients and Methods  Electrodes were implanted bilaterally in the subthalamic nucleus of 23 consecutive patients with Parkinson disease who responded well to levodopa but had severe motor complications. There were 16 men and 7 women (mean ± SEM age, 53 ± 2 years) who had a mean ± SEM disease duration of 14.7 ± 1.0 years. Targets were determined by 3-dimensional magnetic resonance imaging, combined with intraoperative electrophysiologic recordings and stimulation.

Results  Six months after surgery, motor disability, levodopa-induced motor fluctuations, dyskinesias, and the daily dose of levodopa equivalent decreased significantly by 67%, 78%, 77%, and 61%, respectively, compared with the preoperative state. No significant morbidity was observed, except transient depression in 4 patients.

Conclusions  The beneficial effects of subthalamic stimulation depend on (1) the criteria used for patient selection, (2) the precision with which the subthalamic nucleus is targeted (dependent on the 3-dimensional magnetic resonance imaging and the intraoperative electrophysiologic and clinical assessments), and (3) the long-term postoperative adjustment of stimulation variables.


From the Centre d'Investigation Clinique, Fédération de Neurologie and Institut National de la Santé et de la Recherche Médicale, Unit 289 (Drs Houeto, Damier, Bejjani, Staedler, Bonnet, Arnulf, and Agid); and the Services d'Exploration Fonctionnelle Neurologique (Dr Pidoux), de Neuroradiologie (Dr Dormont), and de Neurochirurgie (Dr Cornu), Groupe Hospitalier Pitie-Salpêtrière, Paris, France.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2000;57(4):613-614.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Parkinson's disease, DBS and suicide: a role for serotonin?
Temel et al.
Brain 2009;132:e126-e126.
FULL TEXT  

Improvement in Parkinson Disease by Subthalamic Nucleus Stimulation Based on Electrode Placement: Effects of Reimplantation
Anheim et al.
Arch Neurol 2008;65:612-616.
ABSTRACT | FULL TEXT  

Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?
Derost et al.
Neurology 2007;68:1345-1355.
ABSTRACT | FULL TEXT  

Neurosurgery at an earlier stage of Parkinson disease: A randomized, controlled trial
Schupbach et al.
Neurology 2007;68:267-271.
ABSTRACT | FULL TEXT  

Subthalamic Nucleus Stimulation: Improvements in Outcome With Reprogramming
Moro et al.
Arch Neurol 2006;63:1266-1272.
ABSTRACT | FULL TEXT  

Subthalamic Stimulation in Parkinson Disease: Behavior and Social Adaptation.
Houeto et al.
Arch Neurol 2006;63:1090-1095.
ABSTRACT | FULL TEXT  

Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson's disease
Goodman et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:12-17.
ABSTRACT | FULL TEXT  

Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up
Schupbach et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:1640-1644.
ABSTRACT | FULL TEXT  

Functional improvement after subthalamic stimulation in Parkinson's disease: a non-equivalent controlled study with 12-24 month follow up
Capecci et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:769-774.
ABSTRACT | FULL TEXT  

Parkinson disease, brain volumes, and subthalamic nucleus stimulation
Bonneville et al.
Neurology 2005;64:1598-1604.
ABSTRACT | FULL TEXT  

Subthalamic nucleus stimulation induces deficits in decoding emotional facial expressions in Parkinson's disease
Dujardin et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:202-208.
ABSTRACT | FULL TEXT  

Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease
Devos et al.
Brain 2004;127:408-419.
ABSTRACT | FULL TEXT  

Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: A randomized trial
Esselink et al.
Neurology 2004;62:201-207.
ABSTRACT | FULL TEXT  

Effects of High-Frequency Stimulation on Subthalamic Neuronal Activity in Parkinsonian Patients
Welter et al.
Arch Neurol 2004;61:89-96.
ABSTRACT | FULL TEXT  

MRI directed bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease
Patel et al.
J. Neurol. Neurosurg. Psychiatry 2003;74:1631-1637.
ABSTRACT | FULL TEXT  

Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: evaluation of active electrode contacts
Hamel et al.
J. Neurol. Neurosurg. Psychiatry 2003;74:1036-1046.
ABSTRACT | FULL TEXT  

Subthalamic Stimulation in Parkinson Disease: Intraoperative Predictive Factors
Houeto et al.
Arch Neurol 2003;60:690-694.
ABSTRACT | FULL TEXT  

Deep Brain Stimulation of the Subthalamic Nucleus Enhances Emotional Processing in Parkinson Disease
Schneider et al.
Arch Gen Psychiatry 2003;60:296-302.
ABSTRACT | FULL TEXT  

Subthalamic DBS replaces levodopa in Parkinson's disease: Two-year follow-up
Lang et al.
Neurology 2003;60:154-155.
FULL TEXT  

Effects of Subthalamic Nucleus Stimulation and Levodopa Treatment on Gait Abnormalities in Parkinson Disease
Krystkowiak et al.
Arch Neurol 2003;60:80-84.
ABSTRACT | FULL TEXT  

Parkinson's disease: neurosurgery at an earlier stage?
Mesnage et al.
J. Neurol. Neurosurg. Psychiatry 2002;73:778-778.
FULL TEXT  

Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation
Moro et al.
Brain 2002;125:2408-2417.
ABSTRACT | FULL TEXT  

Subthalamic DBS replaces levodopa in Parkinson's disease
Kleiner-Fisman et al.
Neurology 2002;59:1293-1294.
FULL TEXT  

The impact on Parkinson's disease of electrical parameter settings in STN stimulation
Moro et al.
Neurology 2002;59:706-713.
ABSTRACT | FULL TEXT  

Behavioural disorders, Parkinson's disease and subthalamic stimulation
Houeto et al.
J. Neurol. Neurosurg. Psychiatry 2002;72:701-707.
ABSTRACT | FULL TEXT  

Concurrent excitatory and inhibitory effects of high frequency stimulation: an oculomotor study
Bejjani et al.
J. Neurol. Neurosurg. Psychiatry 2002;72:517-522.
ABSTRACT | FULL TEXT  

Clinical predictive factors of subthalamic stimulation in Parkinson's disease
Welter et al.
Brain 2002;125:575-583.
ABSTRACT | FULL TEXT  

Surgical Treatment of Parkinson Disease
Eskandar et al.
JAMA 2001;286:3056-3059.
FULL TEXT  

Deep brain stimulation in the treatment of Parkinson's disease: A cost-effectiveness analysis
Tomaszewski and Holloway
Neurology 2001;57:663-671.
ABSTRACT | FULL TEXT  

Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD
Hammerstad et al.
Neurology 2001;57:566-567.
FULL TEXT  

Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD
Volkmann et al.
Neurology 2001;56:548-551.
ABSTRACT | FULL TEXT  

The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma
Guridi and Obeso
Brain 2001;124:5-19.
ABSTRACT | FULL TEXT  

Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease
Fraix et al.
Neurology 2000;55:1921-1923.
ABSTRACT | FULL TEXT  

Evidence of functional somatotopy in GPi from results of pallidotomy
Kishore et al.
Brain 2000;123:2491-2500.
ABSTRACT | FULL TEXT  

Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD
Houeto et al.
Neurology 2000;55:728-730.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.